Alaunos Therapeutics | ZIOP - Sales Revenues


Alaunos Therapeutics reported $2K in Sales Revenues for its fiscal quarter ending in March of 2025.





Sales Change Date
Alaunos Therapeutics USD 2K 2K Mar/2025
Amgen USD 10.1B 1.48B Jun/2026
AstraZeneca USD 15.38B 90M Jun/2026
Baxter International USD 2.96B 260M Jun/2026
Biogen USD 2.74B 490M Jun/2026
Bioline Rx USD 477K 283K Mar/2026
Bristol-Myers Squibb USD 12.97B 1.48B Jun/2026
Celltrion KRW 1.24T 90B Jun/2026
Corcept Therapeutics USD 256.15M 91.25M Jun/2026
Cspc Pharmaceutical CNY 6.47B 355.1M Mar/2026
Curis USD 1.14M 1.41M Dec/2025
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Dianthus Therapeutics USD 463K 179K Mar/2026
Divis Laboratories Ltd INR 27.58B 730M Jun/2026
Gilead Sciences USD 7.8B 800M Jun/2026
GlaxoSmithKline GBP 8.41B 781M Jun/2026
Incyte USD 1.67B 400M Jun/2026
Intrexon USD 717K 511K Jun/2024
Ionis Pharmaceuticals USD 268M 22M Jun/2026
J&J USD 25.31B 1.21B Jun/2026
Kangmei Pharma CNY 1.08B 288.27M Mar/2026
Karyopharm Therapeutics USD 35.07M 987K Mar/2026
Knight Therapeutics CAD 133.11M 11.56M Dec/2025
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Medical Developments International AUD 21.57M 12.04M Dec/2025
Merck USD 16.6B 310M Jun/2026
Neuren Pharmaceuticals AUD 42.24M 28.1M Dec/2025
Novartis USD 14.41B 1.3B Jun/2026
Organigram Holdings CAD 59.79M 3.74M Mar/2026
Pfizer USD 15.03B 530M Jun/2026
Pharma Mar EUR 50M 7.1M Jun/2026
PTC Therapeutics USD 361M 88M Jun/2026
Qiagen NV USD 463.12M 43.9M Jun/2026
Regeneron Pharmaceuticals USD 4.29B 690M Jun/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Sangamo BioSciences USD 356K 125K Jun/2024
Sartorius EUR 911.8M 12.7M Jun/2026
Sino Biopharmaceutical CNY 19.44B 5.18B Jun/2026
TG Therapeutics USD 240.34M 45.54M Jun/2026
Tilray USD 217.51M 74.75M Dec/2025
Verastem USD 18.67M 1.14M Mar/2026
Zealand Pharma A/S 34M 34.92M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 2.72B 837.63M Mar/2026